Kidney Today Blog

Anne Rohall, AKF's director public policy, shares her experience participating on the panel, "Upping Our Game: Advances in Clinical Trials for Pediatric Patients" at ASN Kidney Week 2025

Researchers testing a new therapy to prevent organ rejection without using immunosuppressants recently published promising results

Learn more about dialysis fistula and graft bleeds and how you can be prepared for one if it happens

Towana Looney shares her experience receiving a gene-edited pig kidney

In January 2025, FDA approved an injectable form of semaglutide (GLP1-RA) to treat CKD in people with type 2 diabetes. Here are 6 important things you need to know about GLP1-RAs, CKD and the FDA approval.

Two companies have received FDA approval to conduct clinical trials transplanting genetically modified pig kidneys into patients with kidney failure

An overview of five treatments for kidney disease recently approved by the FDA

2023 was a big year for the kidney disease research and it can be challenging to keep up with it all. Fortunately, AKF has been keeping tabs on these headlines for you.

AKF is proud to launch the next step of the UCKD Project: the UCKD Coalition, which is comprised of 15 organizations and individuals who will work together to support policies and actions aimed at identifying kidney disease without a known cause.